Cardiovascular disease isn't just a medical challenge; it's a global economic and emotional crisis. Kardigan isn't managing symptoms—they're aiming to make heart disease curable. This is the story of a team betting everything on a future where heart attacks are a footnote in medical history.

"They aren't building another statin. They're engineering a future where cardiovascular disease is no longer the leading cause of death."

The digital footprint tells a story of focused intent. With 5,740 monthly visits and a global rank hovering around 3 million, Kardigan isn't chasing mass-market traffic. Their 44% direct traffic share is a powerful signal—this is a brand being sought out by investors, potential partners, and industry talent. The organic search strategy is surgical, targeting high-value, clinical keywords like 'severe calcific aortic valve stenosis' rather than generic health queries. This is precision targeting, not vanity metrics.

• Strategic Keyword Focus: Ranking for clinical terms like 'severe calcific aortic valve stenosis' signals deep domain expertise and targets high-intent medical audiences.
• Direct Traffic Dominance: 44% of traffic comes directly to kardigan.bio, indicating strong brand recall and a reputation that precedes it in industry circles.
• Lean Execution: Generating $10.8M in revenue with just 77 employees demonstrates a high-value, low-burn model typical of advanced biotech ventures.
• Tech Stack Paradox: Despite being a biotech, the site uses commercial tools like WooCommerce, suggesting a pragmatic, cost-effective approach to digital presence.